Among active 13F managers last quarter, 5 opened and 9 added, while 6 reduced; the largest holder to move was Marshall Wace, LLP (+103%). Over the last 180 days, 2 insiders sold and none bought, a net -$522K in open-market trades.
The legs disagree, or only one of them leans.
87 tracked 13F filers disclose a position in GALT as of the latest SEC 13F filings, a combined $63.5M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.0M | $13.9M | ▲+274% Added · +2.2M sh | Q2 2026 | |
| 2 | Vanguard Capital Management LLC | 2.2M | $10.1M | ▲+10% Added · +202K sh | Q2 2026 | |
| 3 | Geode Capital Management, LLC | 1.3M | $6.1M | ▲+114% Added · +696K sh | Q2 2026 | |
| 4 | Marshall Wace, LLP | 1.2M | $3.4M | ▲+103% Added · +618K sh | Q1 2026 | |
| 5 | Osaic Holdings, Inc. | 1.1M | $3.1M | ▲+2.9% Added · +32K sh | Q1 2026 | |
| 6 | Millennium Management LLC | 798K | $2.2M | ▲+239% Added · +563K sh | Q1 2026 | |
| 7 | Wealthspire Advisors, LLC | 722K | $2.0M | ▲+20% Added · +120K sh | Q1 2026 | |
| 8 | State Street Corp | 568K | $2.6M | ▲+120% Added · +309K sh | Q2 2026 | |
| 9 | Susquehanna International Group, LLP | 556K | $1.6M | ▲+94% Added · +269K sh | Q1 2026 | |
| 10 | Two Sigma Investments, LP | 467K | $1.3M | ▲28× Added · +450K sh | Q1 2026 | |
| 11 | Commonwealth Equity Services, LLC | 367K | $1.0M | ▲+9.9% Added · +33K sh | Q1 2026 | |
| 12 | Vanguard Fiduciary Trust Co | 366K | $1.7M | ▲+20% Added · +62K sh | Q2 2026 | |
| 13 | Vanguard Portfolio Management LLC | 328K | $1.5M | ▲New +328K sh | Q2 2026 | |
| 14 | LPL Financial LLC | 267K | $745K | ▼−18% Reduced · −58K sh | Q1 2026 | |
| 15 | Sovran Advisors, LLC | 258K | $875K | ▲+0.1% Added · +167 sh | Q2 2026 | |
| 16 | Geneos Wealth Management Inc. | 240K | $1.1M | ▼−0.2% Reduced · −500 sh | Q2 2026 | |
| 17 | Retirement Guys Formula LLC | 211K | $979K | ▲+13% Added · +24K sh | Q2 2026 | |
| 18 | Citadel Advisors LLC | 199K | $922K | ▼−32% Reduced · −92K sh | Q2 2026 | |
| 19 | Jane Street Group, LLC | 195K | $544K | ▼−2.2% Reduced · −4K sh | Q1 2026 | |
| 20 | Goldman Sachs Group Inc | 185K | $515K | ▼−40% Reduced · −122K sh | Q1 2026 | |
| 21 | UBS Group AG | 180K | $501K | ▲+360% Added · +141K sh | Q1 2026 | |
| 22 | Blair William & Co | 149K | $693K | —Held | Q2 2026 | |
| 23 | Renaissance Technologies LLC | 148K | $413K | ▲New +148K sh | Q1 2026 | |
| 24 | Northern Trust Corp | 130K | $364K | —Held | Q1 2026 | |
| 25 | Qube Research & Technologies Ltd | 126K | $353K | ▲+69% Added · +52K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 5 funds opened a new position in GALT and 9 added to an existing one, while 6 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Nvidia CorpNVDA | 35 funds | $91.5B |
| Apple IncAAPL | 35 funds | $62.7B |
| Berkshire Hathaway Inc-CL BBRK/B | 35 funds | $7.8B |
| Microsoft CorpMSFT | 34 funds | $43.2B |
| Amazon.com IncAMZN | 34 funds | $36.6B |
| Alphabet Inc-CL CGOOG | 34 funds | $26.9B |
| Meta Platforms Inc-Class AMETA | 34 funds | $23.0B |
| Tesla IncTSLA | 34 funds | $15.2B |
| Visa Inc-Class A SharesV | 34 funds | $14.6B |
| Chevron CorpCVX | 34 funds | $6.4B |
| Abbott LaboratoriesABT | 34 funds | $4.2B |
| Altria Group IncMO | 34 funds | $1.4B |
Ranked by how many of GALT's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in GALT.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 14, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 16K | $83K |
| Jun 29, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 47K | $239K |
| Jun 29, 2026 | Shlevin Harold H. | Director | Sell (S) | 22K | $112K |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) 2 lots, same day | 5K | $23K |
| Jun 26, 2026 | Shlevin Harold H. | Director | Sell (S) | 8K | $39K |
| Jun 23, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 8K | $24K |
| May 26, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 568 | $2K |
| Feb 6, 2026 | Eldred Kary | Director | Buy (P) | 300 | $810 |
| Jan 6, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 21K | $78K |
| Jan 6, 2026 | Callicutt Jack W | Chief Financial Officer | Sell (S) | 20K | $75K |
| Jan 6, 2026 | Lewis Joel | President and CEO, Director | Sell (S) | 38K | $135K |
| Jan 5, 2026 | Callicutt Jack W | Chief Financial Officer | Sell (S) | 26K | $100K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 30 | 18 | – |
Insiders Form 4 open-market | 0 | 2 | -$522K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for GALT
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/GALT/capital-change-brief"
Use Arkolith's capital_change_brief for GALT. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for GALT. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.